Europe Telemedicine Market Introduction and Overview
According to SPER Market Research, the Europe Telemedicine Market is estimated to reach USD 9.16 billion by 2033 with a CAGR of 9.05%.
The report includes an in-depth analysis of the Europe Telemedicine Market, including market size and trends, product mix, Textile Types, and supplier analysis. Telemedicine utilizes electronic and telecommunications technologies to facilitate the exchange of medical information, enabling healthcare interactions between a patient and their physician, even when they are not physically present in the same location. These interactions can range from basic medical consultations through text messaging to highly sophisticated procedures like remotely controlled surgeries.
- September 2022: Epocrates, a subsidiary of athenahealth, Inc., introduced Bugs + Drugs, a mobile application that provides healthcare professionals with data on bacterial strains and their susceptibility to antibiotics based on geographic locations defined by ZIP codes.
- February 2022: Vayamed, a German company specializing in medical cannabis, has entered into an exclusive partnership with Telaleaf, a telemedicine platform, to enhance the provision of telemedicine services for cannabis therapy in Germany.
Market Opportunities and Challenges
The opportunities for growth in the telemedicine sector in Europe is largely attributed to several key factors, including a high literacy rate, a growing elderly population, improved socio-economic conditions, an increase in chronic diseases, greater adoption of IT solutions in healthcare, heightened demand for primary care services, favourable policy developments, and advancements in telecommunications.
However, several challenges persist in the telemedicine market. The reliable internet connection is essential for telemedicine; nevertheless, certain rural or underserved regions may face limitations in accessing high-speed internet. Some healthcare providers may exhibit hesitation in adopting telemedicine technologies due to either a lack of understanding or concerns about potential impacts on their business models. Similarly, certain patients may be reluctant to embrace telemedicine, preferring in-person care or harboring privacy reservations. Additionally, the lack of insurance coverage for telemedicine services in certain countries may serve as a deterrent to its utilization.
Market Competitive Landscape
The European telemedicine market exhibits a moderate level of competitiveness, characterized by the presence of numerous companies operating on both a global and regional scale. The competitive landscape involves an assessment of several international and local firms that command substantial market shares and enjoy widespread recognition. Some of these prominent players include Aerotel Medical Systems Ltd, Allscripts Healthcare Solutions Inc., AMD Global Telemedicine Inc., International Business Machinery Corporation, OTH.IO, Resideo Technologies Inc., Teladoc Health Inc., Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Type, By Component, By Mode of Delivery, By End User
|
| Regions covered | France, Germany, Italy, Spain, United Kingdom, Rest of Europe
|
| Companies Covered | Aerotel Medical Systems Ltd, Allscripts Healthcare Solutions Inc., AMD Global Telemedicine Inc., International Business Machinery Corporation, OTH.IO, Resideo Technologies Inc., Teladoc Health Inc., Others
|
COVID-19 Impact on Europe Telemedicine Market
The rapid surge in COVID-19 cases across Europe, particularly affecting countries like Spain, Italy, Germany, France, and the UK, has had a profound impact on the European economy. The declaration of the COVID-19 outbreak as a pandemic by the World Health Organization marked a significant shift in medical practice. As quarantine measures and social distancing became the norm, in-person medical visits sharply declined, catapulting telemedicine to the forefront of healthcare. In response to the outbreak, Scotland has made progress by collaborating on a decision support tool for predicting severe COVID-19 cases. Telemedicine has witnessed a substantial surge in adoption during the pandemic, becoming the new standard for accessing healthcare.
Key Target Audience
- Health Insurance Companies
- Healthcare Facilities
- Healthcare Providers
- Home Health Services
- Investors and Venture Capitalists
- Medical Device Manufacturers
- Mental Health Professionals
- Patients
- Pharmaceutical Companies
- Pharmacies
- Telecommunication Companies
- Telemedicine Technology Companies
- Others
Our in-depth analysis of the Europe Telemedicine Market includes the following segments:
|
By Type
|
mHealth (Mobile Health)
Telehomes
|
|
By Component:
|
Products
Services
|
|
By Application:
|
Cloud-based Delivery
On-premise Delivery
|
|
By End User:
|
Tele-Homes
Tele-Hospitals
Others
|
Key Topics Covered in the Report
- Europe Telemedicine Market Size (FY’2023-FY’2033)
- Overview of Europe Telemedicine Market
- Segmentation of Europe Telemedicine Market By Type (mHealth, Telehomes)
- Segmentation of Europe Telemedicine Market By Component (Products, Services)
- Segmentation of Europe Telemedicine Market By Mode of Delivery (Cloud-based Delivery, On-premise Delivery)
- Segmentation of Europe Telemedicine Market By End User (Tele-Homes, Tele-Hospitals, Others)
- Statistical Snap of Europe Telemedicine Market
- Expansion Analysis of Europe Telemedicine Market
- Problems and Obstacles in Europe Telemedicine Market
- Competitive Landscape in the Europe Telemedicine Market
- Impact of COVID-19 and Demonetization on Europe Telemedicine Market
- Details on Current Investment in Europe Telemedicine Market
- Competitive Analysis of Europe Telemedicine Market
- Prominent Players in the Europe Telemedicine Market
- SWOT Analysis of Europe Telemedicine Market
- Europe Telemedicine Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst